# STEGLUJAN

NDC: 0006-5367
Generic name: ertugliflozin and sitagliptin
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20171219

FDA application: NDA209805

## Active ingredients

- ERTUGLIFLOZIN PIDOLATE: 5 mg/1
- SITAGLIPTIN PHOSPHATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5367"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5367
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2c553d8-5a9d-4366-bf53-8bdb5a876d19